MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
67 hedge funds and large institutions have $126M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 63 → 67 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
67
Holding in Top 10
4
Calls
$3.67M
Puts
$2.07M
Top Buyers
| 1 | +$3.73M | |
| 2 | +$1.69M | |
| 3 | +$1.16M | |
| 4 |
BlackRock
New York
|
+$708K |
| 5 |
Renaissance Technologies
New York
|
+$656K |
Top Sellers
| 1 | -$2.32M | |
| 2 | -$1.02M | |
| 3 | -$637K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$176K |
| 5 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$134K |